<unk> s are usually more rapidly progressive and less likely to respond to antiparkinsonian medication than PD. However, the additional features of the diseases may respond to medications not used in PD. Current therapy for<unk> s is centered around a multidisciplinary treatment of symptoms. These disorders have been linked to pesticide exposure.
Parkinson-plus syndrome
Huntington's disease-like syndrome
X-linked dystonia parkinsonism
Sydenham's chorea
Wernicke–Korsakoff syndrome
Stratton Parker syndrome
Dopamine-responsive dystonia
Progressive supranuclear palsy